KOE:048410
Hyundai Bioscience Co., Ltd. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:23 UTC
Last close
n/aKRW
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-629.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-528.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.16Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Growth is the furthest below its sector's middle: 0.07 against 0.50 on the market's range.
- Growth-22.4%7 of 100, below its sector
- Returns on capital-20.0%27 of 100, above its sector
- Margins-29.2%6 of 100, below its sector
- Price4.9x11 of 100, below its sector
- Safety0.1676 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
0 yes of 4 answered- 1Does it earn money?no
net margin, read above 0.
- 2Can it pay what it owes?Not known
interest coverage, read above 3. We do not hold that figure for this company.
- 3Is it bigger than five years ago?no
rev growth 5y, read above 0.
- 4Does the profit turn into cash?no
fcf margin, read above 0.
- 5Is it issuing shares?no
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?Not known
pe ratio, read below 20. We do not hold that figure for this company.
2 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.
0 of 4 questions answered yes; 2 could not be answered.
0 of 4 questions answered yes; 2 could not be answered.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Does it earn money?-629.1%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Can it pay what it owes?n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it bigger than five years ago?-22.4%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Does the profit turn into cash?-528.5%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it issuing shares?20.6%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it priced under twenty times earnings?n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW